Tweet
Emerg Infect Dis
. 2022 Jul;28(7):1531-1533.
doi: 10.3201/eid2807.220198.
Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
Jani M Kim, Geetha Sivasubramanian
- PMID: 35731220
- DOI: 10.3201/eid2807.220198
Abstract
Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Strongyloides screening and treatment in high-risk populations.
Keywords: COVID-19; SARS; SARS-CoV-2; Strongyloides; Strongyloides stercoralis; coronavirus; coronavirus disease; parasites; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.